Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - The lancet, 2003 - thelancet.com
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - The Lancet, 2003 - thelancet.com
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
[引用][C] Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - The Lancet, 2003 - cir.nii.ac.jp
Assessment and management of cancer-related fatigue in adults | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman… - Lancet (London …, 2003 - pubmed.ncbi.nlm.nih.gov
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
Assessment and management of cancer-related fatigue in adults.
K Ahlberg, T Ekman, F Gaston-Johansson… - Lancet (London …, 2003 - europepmc.org
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - The Lancet, 2003 - Elsevier
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - Lancet, 2003 - pure.johnshopkins.edu
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - The Lancet, 2003 - infona.pl
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
Assessment and management of cancer-related fatigue in adults.
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - The Lancet, 2003 - psycnet.apa.org
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …
[PDF][PDF] Assessment and management of cancer-related fatigue in adults
K Ahlberg, T Ekman, F Gaston-Johansson, V Mock - THE LANCET, 2003 - academia.edu
Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …
side-effect of many of the treatments available for the management of malignant disease. We …